We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Albemarle (ALB) Suffers a Larger Drop Than the General Market: Key Insights
Read MoreHide Full Article
In the latest trading session, Albemarle (ALB - Free Report) closed at $92.54, marking a -2.04% move from the previous day. The stock fell short of the S&P 500, which registered a loss of 1.21% for the day. Meanwhile, the Dow gained 0.02%, and the Nasdaq, a tech-heavy index, lost 2.6%.
Heading into today, shares of the specialty chemicals company had lost 16.75% over the past month, lagging the Basic Materials sector's loss of 4.8% and the S&P 500's loss of 0.03%.
The upcoming earnings release of Albemarle will be of great interest to investors. The company's earnings report is expected on November 4, 2026. The company's earnings per share (EPS) are projected to be $2.39, reflecting a 1357.89% increase from the same quarter last year. Meanwhile, the latest consensus estimate predicts the revenue to be $1.49 billion, indicating a 14.15% increase compared to the same quarter of the previous year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $11.19 per share and a revenue of $6.09 billion, signifying shifts of +1516.46% and +18.41%, respectively, from the last year.
Investors should also take note of any recent adjustments to analyst estimates for Albemarle. These revisions help to show the ever-changing nature of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, there's been a 1.79% fall in the Zacks Consensus EPS estimate. Currently, Albemarle is carrying a Zacks Rank of #3 (Hold).
With respect to valuation, Albemarle is currently being traded at a Forward P/E ratio of 8.45. Its industry sports an average Forward P/E of 15.5, so one might conclude that Albemarle is trading at a discount comparatively.
We can additionally observe that ALB currently boasts a PEG ratio of 0.56. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. By the end of yesterday's trading, the Chemical - Diversified industry had an average PEG ratio of 1.2.
The Chemical - Diversified industry is part of the Basic Materials sector. This group has a Zacks Industry Rank of 198, putting it in the bottom 20% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow ALB in the coming trading sessions, be sure to utilize Zacks.com.
View the Zacks #1 Rank List
Image: Bigstock
Albemarle (ALB) Suffers a Larger Drop Than the General Market: Key Insights
In the latest trading session, Albemarle (ALB - Free Report) closed at $92.54, marking a -2.04% move from the previous day. The stock fell short of the S&P 500, which registered a loss of 1.21% for the day. Meanwhile, the Dow gained 0.02%, and the Nasdaq, a tech-heavy index, lost 2.6%.
Heading into today, shares of the specialty chemicals company had lost 16.75% over the past month, lagging the Basic Materials sector's loss of 4.8% and the S&P 500's loss of 0.03%.
The upcoming earnings release of Albemarle will be of great interest to investors. The company's earnings report is expected on November 4, 2026. The company's earnings per share (EPS) are projected to be $2.39, reflecting a 1357.89% increase from the same quarter last year. Meanwhile, the latest consensus estimate predicts the revenue to be $1.49 billion, indicating a 14.15% increase compared to the same quarter of the previous year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $11.19 per share and a revenue of $6.09 billion, signifying shifts of +1516.46% and +18.41%, respectively, from the last year.
Investors should also take note of any recent adjustments to analyst estimates for Albemarle. These revisions help to show the ever-changing nature of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, there's been a 1.79% fall in the Zacks Consensus EPS estimate. Currently, Albemarle is carrying a Zacks Rank of #3 (Hold).
With respect to valuation, Albemarle is currently being traded at a Forward P/E ratio of 8.45. Its industry sports an average Forward P/E of 15.5, so one might conclude that Albemarle is trading at a discount comparatively.
We can additionally observe that ALB currently boasts a PEG ratio of 0.56. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. By the end of yesterday's trading, the Chemical - Diversified industry had an average PEG ratio of 1.2.
The Chemical - Diversified industry is part of the Basic Materials sector. This group has a Zacks Industry Rank of 198, putting it in the bottom 20% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow ALB in the coming trading sessions, be sure to utilize Zacks.com.